We continue to be active in research and routinely present our research annually at National and International meetings. In addition, we publish our research regularly in multiple peer reviewed journals.

Title: Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)

Brief Description: Comparing Albuterol v. Albuterol + Budesonide
Sponsor: AstraZeneca
PI: Sankaran Krishnan
Learn more: https://clinicaltrials.gov/study/NCT06307665?term=acadia&rank=1

Title: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (EXHALE-2)

Brief Description: New Oral Agent for Asthma
Sponsor: Areteia Therapeutics 
PI: Sankaran Krishnan
Learn more:  https://clinicaltrials.gov/study/NCT05763121?term=exhale-2&rank=1

Title: Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH)

Brief Description: New Anti-inflammatory for Asthma 
Sponsor: AstraZeneca
PI: Sankaran Krishnan
Learn more:  https://clinicaltrials.gov/study/NCT05251259?term=astrazeneca%20flash&rank=1

Title: Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/ Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

Brief Description: Biologic for 2-5 Year Olds
Sponsor: Sanofi
PI: Sankaran Krishnan
Learn more:  https://clinicaltrials.gov/study/NCT06191315?term=trekids&rank=1 

Title: Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/ Long-acting Beta-agonist (ICS/ LABA) in Comparison to ICS Dose Escalation to High Dose ICS/ LABA in Adolescent and Adult Patients With Uncontrolled Asthma (AIM4:Next Step)

Brief Description: Biologic Added to Medium Dose Controller Medication v. High Dose Controller Medication Alone
Sponsor: Regeneron 
PI: Sankaran Krishnan
Learn more:  https://clinicaltrials.gov/study/NCT06572228?term=R668-AS-2373&rank=1

Title: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/ Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Brief Description: Albuterol v. Albuterol + Fluticasone 
Sponsor: Teva Pharmaceuticals 
PI: Allen Dozor
Learn more:  https://clinicaltrials.gov/study/NCT06052267?term=FpA-AS-30094&rank=1

Title: A Phase 1 Study Evaluating Safety and Tolerability of RCT2100 in Healthy Participants and in Participants With CF

Brief Description: New mRNA Therapy for CF
Sponsor: ReCode Therapeutics 
PI: Allen Dozor
Learn more:  https://clinicaltrials.gov/study/NCT06237335?term=rct2100&rank=1

Title: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study (STOP360AG)

Brief Description: 1 IV Antibiotic v. 2 IV Antibiotics for treatment of Pulmonary Exacebation with Pseudomonas
Sponsor: Cystic Fibrosis Foundation
PI: Allen Dozor
Learn more:  https://clinicaltrials.gov/study/NCT05548283?term=stop-360&rank=1

Title: Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Brief Description: Observational Study For People With CF
Sponsor: Cystic Fibrosis Foundation
PI: Allen Dozor
Learn more:  https://clinicaltrials.gov/study/NCT05639556?term=strong-cf&rank=1

Title: A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Brief Description: Observational Study For People With CF Not Taking Modulators 
Sponsor: Cystic Fibrosis Foundation
PI: John Welter
Learn more:  https://clinicaltrials.gov/study/NCT06504589?term=REACH-OB-23&rank=1

Title: A Study to Evaluate the Safety of CMTX-101 in People with Cystic Fibrosis

Brief Description: New IV Drug for People With CF with Pseudomonas 
Sponsor: Clarametyx Biosciences
PI: John Welter
Learn more:  https://clinicaltrials.gov/study/NCT06159725?term=CMTX101&rank=2

Title: Study of Oral Upadacitinib and Subcutaneous/ Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. (SELECT-sJIA)

Brief Description: Comparing Two Biologics for Systemic Juvenile Idiopathic Arthritis 
Sponsor: AbbVie
PI: Christine Hom
Learn more:  https://clinicaltrials.gov/study/NCT05609630?term=m14682&rank=1

Title: A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab (KnaPsAck)

Brief Description: Comparing Two Biologics for Juvenile Psoriatic Arthritis
Sponsor: AbbVie
PI: Christine Hom
Learn more:  https://clinicaltrials.gov/study/NCT06100744?term=m23732&rank=1

Title: A Phase 2 Basket Study of Vosoritide in Children With Turner Syndrome, SHOX Deficiency and Noonan Syndrome With an Inadequate Response to Human Growth Hormone

Brief Description: Comparing Two Types of Growth Hormone for Children with Turner, SHOX, or Noonan
Sponsor: BioMarin Pharmaceutical
PI: Shilpa Mehta
Learn more:  https://clinicaltrials.gov/study/NCT06668805?term=111-211&rank=2

Locations

19 Bradhurst Avenue
Suite 1400
Hawthorne, NY 10532
United States

222 Westchester Avenue
Suite 300
West Harrison, NY 10604
United States

1 South Greeley Avenue
Suite 303
Chappaqua, NY 10514
United States

212 Crystal Run Road
Middletown, NY 10941
United States

266 North Street
Suite B
Newburgh, NY 12550
United States

257 Lafayette Avenue
Suite 370
Suffern, NY 10901
United States

1 Webster Avenue
Suite 300, Mid-Hudson Regional Hospital Atrium Building
Poughkeepsie, NY 12601
United States

32 Strawberry Hill Court
Suite 7
Stamford, CT 06902
United States